Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Lancet HIV. 2017 Mar 30;4(7):e303–e310. doi: 10.1016/S2352-3018(17)30045-0

Figure 2. Percentage of incident HIV infections averted attributable to harm reduction services and the preventive benefits of ART via needle sharing.

Figure 2

Figure 2

Panel A: Estimated independent effects of harm reduction services and ART on HIV incidence among PLHIV

Panel B: Estimated independent effects of needle distribution and OAT on HIV incidence among PLHIV

Grey-shaded area represents the combined effect of harm reduction (including NDP and OAT) and ART (Scenario S1) * indicates baseline ART efficacy assumption in reducing HIV transmission via needle sharing.